Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acusensus's other long-term liabilities for the quarter that ended in Dec. 2025 was A$6.39 Mil.
Acusensus's quarterly other long-term liabilities
increased
from Dec. 2024 (A$1.68 Mil) to Jun. 2025 (A$5.67 Mil) and
increased
from Jun. 2025 (A$5.67 Mil) to Dec. 2025 (A$6.39 Mil).
Acusensus's annual other long-term liabilities
increased
from Jun. 2023 (A$0.09 Mil) to Jun. 2024 (A$0.72 Mil) and
increased
from Jun. 2024 (A$0.72 Mil) to Jun. 2025 (A$5.67 Mil).
Acusensus Other Long-Term Liabilities Related Terms
Acusensus Other Long-Term Liabilities Historical Data
* Premium members only.
The historical data trend for Acusensus's Other Long-Term Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
What does a Other Long-Term Liabilities of A$6.39 Mil mean?
Acusensus (ASX:ACE) has a Other Long-Term Liabilities of A$6.39 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Acusensus and its competitors.
Is Acusensus' Other Long-Term Liabilities too high?
Acusensus' current Other Long-Term Liabilities is A$6.39 Mil. Overall, Acusensus has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Acusensus' Other Long-Term Liabilities compare to MSFT and ORCL?
Acusensus' Other Long-Term Liabilities of A$6.39 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Software company?
A good Other Long-Term Liabilities depends on the Software industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Acusensus and its competitors. Acusensus's current Other Long-Term Liabilities is A$6.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.50, compared to a current price of A$0.99 — trading 34.3% below its estimated fair value. The current Other Long-Term Liabilities is A$6.39 Mil. Acusensus' overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current Other Long-Term Liabilities is A$6.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acusensus (ASX:ACE) Overvalued in 2026?
Based on GuruFocus' analysis, Acusensus stock appears to be undervalued.
The current stock price of A$0.99 is trading 34.3% below its estimated GF Value™ of A$1.50.
GuruFocus considers Acusensus to be Possible Value Trap.
Key valuation signals for ASX:ACE:
Other Long-Term Liabilities: A$6.39 Mil
GF Value™: A$1.50 vs. price of A$0.99 (34.3% below fair value)
No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
56GF Score
Get the complete analysis for ASX:ACE
Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ACE has been successfully added to your 
